Leonard H. Van Den Berg

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 512 publications

The EQ-5D-5L in amyotrophic lateral sclerosis: an international longitudinal exploration as part of ALS-CarE.

The EQ-5D-5L in amyotrophic lateral sclerosis: an international longitudinal exploration as part of ALS-CarE.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: August 13, 2026

Lessons from a systematic review of family-based studies in ALS.

Lessons from a systematic review of family-based studies in ALS.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: August 12, 2026

Feasibility and sensitivity of a multimodal digital endpoint panel for amyotrophic lateral sclerosis: a prospective cohort study.

Feasibility and sensitivity of a multimodal digital endpoint panel for amyotrophic lateral sclerosis: a prospective cohort study.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: July 06, 2026

Gold Coast criteria for ALS diagnosis: individual participant data meta-analysis.

Gold Coast criteria for ALS diagnosis: individual participant data meta-analysis.

Journal: Journal of neurology

Published: June 23, 2026

Diagnostic Revision From Primary Lateral Sclerosis to Amyotrophic Lateral Sclerosis: A Cohort Study.

Diagnostic Revision From Primary Lateral Sclerosis to Amyotrophic Lateral Sclerosis: A Cohort Study.

Journal: Neurology

Published: May 29, 2026

Clinical drug development in amyotrophic lateral sclerosis: industry-reported challenges and opportunities.

Clinical drug development in amyotrophic lateral sclerosis: industry-reported challenges and opportunities.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: May 20, 2026

Tofersen treatment in respiratory onset amyotrophic lateral sclerosis and a variant of uncertain significance in SOD1; a case report.

Tofersen treatment in respiratory onset amyotrophic lateral sclerosis and a variant of uncertain significance in SOD1; a case report.

Journal: European journal of human genetics : EJHG

Published: April 28, 2026

Heterogeneity in the Analysis of the ALSFRS-R in ALS Clinical Trials and its Effect on the Validity and Precision of Trial Conclusions.

Heterogeneity in the Analysis of the ALSFRS-R in ALS Clinical Trials and its Effect on the Validity and Precision of Trial Conclusions.

Journal: Neurology

Published: April 21, 2026

Fast and controlled access to tofersen for SOD1-related amyotrophic lateral sclerosis in The Netherlands; experiences using the orphan drug access protocol.

Fast and controlled access to tofersen for SOD1-related amyotrophic lateral sclerosis in The Netherlands; experiences using the orphan drug access protocol.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: April 13, 2026

Quantifying motor unit loss prior to functional impairment in muscles affected by amyotrophic lateral sclerosis.

Quantifying motor unit loss prior to functional impairment in muscles affected by amyotrophic lateral sclerosis.

Journal: Clinical neurophysiology practice

Published: March 18, 2026

ALS motor phenotypes: a revised 'OPM' classification.

ALS motor phenotypes: a revised 'OPM' classification.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 17, 2026

How to measure person-centred care in people living with ALS: development and validation of the patient experience PEMALS questionnaire.

How to measure person-centred care in people living with ALS: development and validation of the patient experience PEMALS questionnaire.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 10, 2026

Showing 1-12 of 512

Last Updated: 09/26/2026